Is transcranial magnetic stimulation (TMS) safe to undergo while I am taking clonazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

TMS is Generally Safe with Clonazepam, Though Benzodiazepines May Reduce Treatment Efficacy

Yes, you can safely undergo TMS while taking clonazepam, as there are no absolute contraindications or significant safety concerns with this combination. However, you should be aware that benzodiazepines like clonazepam may potentially reduce the therapeutic effectiveness of TMS treatment.

Safety Considerations

No Direct Safety Contraindications

The comprehensive TMS safety guidelines do not identify benzodiazepines as contraindications for TMS treatment 1, 2. The primary safety concern with TMS is seizure induction, and while benzodiazepines theoretically affect seizure threshold, the actual risk of TMS-induced seizures remains extremely low even in patients taking CNS-active medications 1.

Theoretical Seizure Risk is Minimal

The 2019 consensus paper on TMS for addiction medicine notes that factors increasing seizure risk (including benzodiazepine use/withdrawal) could theoretically increase brain sensitivity to TMS-induced seizures 3. However, updated 2021 safety guidelines emphasize that seizure risk with TMS is low, even in patients taking drugs acting on the central nervous system, when using traditional stimulation parameters 1.

Standard Precautions Apply

Your TMS provider should:

  • Screen for any history of seizures or neurological conditions
  • Monitor you during treatment sessions
  • Use established stimulation parameters within safety guidelines
  • Be aware of your complete medication regimen 1, 2

Efficacy Considerations: The More Important Issue

Benzodiazepines May Reduce TMS Effectiveness

The more clinically relevant concern is that clonazepam may diminish the antidepressant effects of TMS, not that it poses a safety risk. The evidence on this is mixed but concerning:

Evidence suggesting reduced efficacy:

  • A 2021 naturalistic study found that patients taking lorazepam (another benzodiazepine) had significantly lower response rates to TMS: only 18% responders compared to 38% in the non-benzodiazepine group 4
  • This study specifically noted that the intake regimen of lorazepam did not affect outcomes—any use appeared problematic 4

Contradictory evidence:

  • A 2024 Australian study found no difference in response, remission, or symptom improvement between patients taking benzodiazepines during TMS versus those not taking them 5
  • Both groups showed significant decreases in depression and anxiety scores 5

Mechanism of Interference

Benzodiazepines enhance GABAergic inhibition in the brain, which may counteract TMS's ability to modulate cortical excitability and induce neuroplastic changes necessary for therapeutic benefit 4. Clonazepam specifically has a long half-life (30-40 hours) 6, meaning it maintains consistent CNS effects that could continuously dampen TMS-induced neuroplasticity.

Clinical Recommendations

Discuss Tapering with Your Prescriber

Before starting TMS, have a detailed conversation with both your TMS provider and the prescriber of your clonazepam about whether tapering is appropriate. Consider:

  • Why you're taking clonazepam: If it's for seizure control, continuing is essential. If it's for anxiety or sleep, alternatives might be considered
  • Duration of use: Long-term benzodiazepine use requires very gradual tapering to avoid withdrawal seizures 6, 7
  • Risk of withdrawal: Abrupt discontinuation of clonazepam can cause life-threatening withdrawal reactions including seizures 6, 7

If Tapering is Considered

The 2025 joint clinical practice guideline on benzodiazepine tapering emphasizes 7:

  • Never discontinue abruptly in patients likely to be physically dependent
  • Use individualized, gradual tapering strategies
  • Offer adjunctive psychosocial interventions to support successful tapering
  • Employ shared decision-making with ongoing risk-benefit assessment

If Continuing Clonazepam During TMS

If tapering isn't feasible or appropriate:

  • Proceed with TMS—it remains a reasonable treatment option
  • Be aware that response rates may be lower
  • Consider more intensive TMS protocols if available (though evidence for this approach is limited)
  • Monitor response carefully and adjust treatment plans accordingly

Common Pitfalls to Avoid

  1. Don't stop clonazepam abruptly before TMS—this creates serious withdrawal and seizure risks that far outweigh any potential benefit 6
  2. Don't assume benzodiazepines are an absolute contraindication—they're not, and many patients successfully receive TMS while taking them 5
  3. Don't ignore the efficacy question—have an explicit discussion about whether the potential reduction in TMS effectiveness changes your treatment plan 4

Bottom Line

TMS is safe with clonazepam from a side effect and adverse event perspective. The real question is whether clonazepam may reduce how well TMS works for you. This requires a nuanced discussion with your treatment team about the risks and benefits of continuing versus tapering clonazepam, always remembering that any benzodiazepine discontinuation must be done gradually and carefully to avoid dangerous withdrawal effects.

Related Questions

In a 70-year-old female on polypharmacy who is taking multiple psychotropic agents (including clonazepam for anxiety‑related restlessness and crying), which medication should be tapered first?
In a 23‑year‑old woman who ingested 20 tablets of alprazolam 0.5 mg and 10 tablets of amlodipine 5 mg 24 hours ago, now neurologically intact (Glasgow Coma Scale E4 M6 V4) but drowsy, with blood pressure 120/80 mmHg, tachycardia (heart rate 120 bpm), respiratory rate 16/min, arterial oxygen tension 120 mmHg and carbon dioxide tension 40 mmHg, what aspects should the emergency physician evaluate and monitor?
What are the potential adverse effects and administration protocols of Transcranial Magnetic Stimulation (TMS)?
How should I manage a patient whose acute symptoms resolved after lorazepam but who reports a possible allergic reaction to an unknown chemotherapy regimen two weeks ago?
What is the diagnosis and recommended medication management (dose and frequency) for a 62-year-old woman who abruptly stopped chronic alprazolam 1 mg five times daily and now presents with disorganized speech and seizures, while currently taking mirtazapine 45 mg nightly and lamotrigine 200 mg three times daily for seizures?
When and how should BCG vaccination be used for leprosy prevention, including dosing, contraindications, and alternative prophylaxis?
What is the recommended simethicone dosage for an infant, including dose per feeding and maximum daily amount?
What is the rationale for using famotidine instead of omeprazole in a patient with chronic kidney disease?
Is taking 0.5 mg of clonazepam three times daily safe?
Is there an age limit for undergoing a treadmill exercise stress test?
What is the difference between betamethasone dipropionate and betamethasone valerate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.